These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 23308242

  • 21. ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.
    Choi BK, Fan X, Deng H, Zhang N, An Z.
    Cancer Med; 2012 Aug; 1(1):28-38. PubMed ID: 23342251
    [Abstract] [Full Text] [Related]

  • 22. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
    Samant GV, Sylvester PW.
    Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
    [Abstract] [Full Text] [Related]

  • 23. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
    Grøvdal LM, Kim J, Holst MR, Knudsen SL, Grandal MV, van Deurs B.
    Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604
    [Abstract] [Full Text] [Related]

  • 24. Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKCɛ-Akt-ERK1/2 signaling pathway in activated microglial cells.
    Merighi S, Gessi S, Varani K, Fazzi D, Stefanelli A, Borea PA.
    Biochem Pharmacol; 2013 Aug 15; 86(4):487-96. PubMed ID: 23796752
    [Abstract] [Full Text] [Related]

  • 25. Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling.
    Ieguchi K, Fujita M, Ma Z, Davari P, Taniguchi Y, Sekiguchi K, Wang B, Takada YK, Takada Y.
    J Biol Chem; 2010 Oct 08; 285(41):31388-98. PubMed ID: 20682778
    [Abstract] [Full Text] [Related]

  • 26. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
    Kim A, Liu B, Ordonez-Ercan D, Alvarez KM, Jones LD, McKimmey C, Edgerton SM, Yang X, Thor AD.
    Breast Cancer Res; 2005 Oct 08; 7(5):R708-18. PubMed ID: 16168116
    [Abstract] [Full Text] [Related]

  • 27. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.
    Smirnova T, Zhou ZN, Flinn RJ, Wyckoff J, Boimel PJ, Pozzuto M, Coniglio SJ, Backer JM, Bresnick AR, Condeelis JS, Hynes NE, Segall JE.
    Oncogene; 2012 Feb 09; 31(6):706-15. PubMed ID: 21725367
    [Abstract] [Full Text] [Related]

  • 28. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S, Horváth G, Knuechel-Clarke R, Hofstaedter F, Szöllosi J, Brockhoff G.
    Exp Cell Res; 2005 Apr 01; 304(2):604-19. PubMed ID: 15748904
    [Abstract] [Full Text] [Related]

  • 29. Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab.
    Wang SE, Xiang B, Guix M, Olivares MG, Parker J, Chung CH, Pandiella A, Arteaga CL.
    Mol Cell Biol; 2008 Sep 01; 28(18):5605-20. PubMed ID: 18625725
    [Abstract] [Full Text] [Related]

  • 30. Computational modeling of ERBB2-amplified breast cancer identifies combined ErbB2/3 blockade as superior to the combination of MEK and AKT inhibitors.
    Kirouac DC, Du JY, Lahdenranta J, Overland R, Yarar D, Paragas V, Pace E, McDonagh CF, Nielsen UB, Onsum MD.
    Sci Signal; 2013 Aug 13; 6(288):ra68. PubMed ID: 23943608
    [Abstract] [Full Text] [Related]

  • 31. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N, Möllmann K, Milde-Langosch K, Müller V, Schumacher U, Brandt B, Pantel K, Jücker M.
    Cell Signal; 2014 May 13; 26(5):1021-9. PubMed ID: 24463007
    [Abstract] [Full Text] [Related]

  • 32. Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes.
    Eldridge S, Guo L, Mussio J, Furniss M, Hamre J, Davis M.
    Toxicol Sci; 2014 Oct 13; 141(2):547-59. PubMed ID: 25055963
    [Abstract] [Full Text] [Related]

  • 33. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M, Grijalva R, Yu D.
    Cancer Res; 1999 Apr 01; 59(7):1620-5. PubMed ID: 10197638
    [Abstract] [Full Text] [Related]

  • 34. Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer.
    Tao JJ, Castel P, Radosevic-Robin N, Elkabets M, Auricchio N, Aceto N, Weitsman G, Barber P, Vojnovic B, Ellis H, Morse N, Viola-Villegas NT, Bosch A, Juric D, Hazra S, Singh S, Kim P, Bergamaschi A, Maheswaran S, Ng T, Penault-Llorca F, Lewis JS, Carey LA, Perou CM, Baselga J, Scaltriti M.
    Sci Signal; 2014 Mar 25; 7(318):ra29. PubMed ID: 24667376
    [Abstract] [Full Text] [Related]

  • 35. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C, Carraway KL.
    Cancer Res; 2006 Dec 01; 66(23):11279-86. PubMed ID: 17145873
    [Abstract] [Full Text] [Related]

  • 36. Neuregulin 1 up-regulates the expression of nicotinic acetylcholine receptors through the ErbB2/ErbB3-PI3K-MAPK signaling cascade in adult autonomic ganglion neurons.
    Kim HG, Lee CK, Cho SM, Whang K, Cha BH, Shin JH, Song KH, Jeong SW.
    J Neurochem; 2013 Feb 01; 124(4):502-13. PubMed ID: 23199222
    [Abstract] [Full Text] [Related]

  • 37. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Way TD, Kao MC, Lin JK.
    J Biol Chem; 2004 Feb 06; 279(6):4479-89. PubMed ID: 14602723
    [Abstract] [Full Text] [Related]

  • 38. Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.
    Hutcheson IR, Goddard L, Barrow D, McClelland RA, Francies HE, Knowlden JM, Nicholson RI, Gee JM.
    Breast Cancer Res; 2011 Mar 11; 13(2):R29. PubMed ID: 21396094
    [Abstract] [Full Text] [Related]

  • 39. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
    Bhat-Nakshatri P, Sweeney CJ, Nakshatri H.
    Oncogene; 2002 Mar 27; 21(13):2066-78. PubMed ID: 11960379
    [Abstract] [Full Text] [Related]

  • 40. Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells.
    Wang S, Huang J, Lyu H, Lee CK, Tan J, Wang J, Liu B.
    Cell Death Dis; 2013 Mar 21; 4(3):e556. PubMed ID: 23519125
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.